Circulating Tumor Cells Market Size, Future Impressive Growth Rate And Development Analysis 2023 To 2031

(MENAFN- Alliance News) Astute Analytica publishes a research report on the global Circulating Tumor Cells Market. The analysis report contains in-depth data about demand, growth, opportunities, challenges, and restraints. In addition, it provides a thorough examination of the structure and possibility of global and regional industries.

The Global Circulating Tumor Cells Market was valued at US$ 8.9 billion in 2022 and is projected to surpass the market size of US$ 17.6 billion by 2031 at a CAGR of 8.06% during the forecast period 2023-2031. It analyses the markets regional trends, size, expansion prospects, and important factors in each region. Additionally, it acknowledges the impact of COVID-19, including updates on the Omicron mutation study, on the market. Both the direct and indirect effects of the pandemic on related industries are taken into account and discussed in the report.

The report gives a thorough analysis of the global Circulating Tumor Cells Market , covering regional trends, market size, prospects for expansion, and important market factors in each region. In 2021, the United States Gross Domestic Product (GDP) value was US$ 23,315.08 billion, according to verified data from the World Bank. In terms of GDP, the United States accounts for 10.41% of the global economy. The mixed economy of the United States is very advanced. By nominal GDP, it has the largest economy in the world, and by purchasing power parity (PPP), it is second only to China in size.

The leading companies mentioned are

• Greiner Bio One International GmbH
• Advanced Cell Diagnostics Inc.
• Aviva Biosciences
• Biocept, Inc.
• BioFluidica
• Bio-Techne Corporation
• Creatv Micro Tech Inc.
• Fluxion Biosciences, Inc.
• LungLife AI Inc.
• Menarini Silicon Biosystems
• Miltenyi Biotec
• Precision for Medicine
• QIAGEN
• Rarecells Diagnostics
• ScreenCell
• Sysmex Corporation
• Other Prominent players

The report also acknowledges the impact of COVID-19, including updates on the Omicron mutation study, on the market. It considers both the direct impact of the pandemic and the indirect influence on related industries. The observations on the pandemics impact are included in the report.

Furthermore, the report divides geographical regions into several major categories for production, consumption, revenue (in US dollars), and market share analysis. It discusses the predicted growth of the market in these regions between 2021 and 2031.

The segmentation overview of the global Circulating Tumor Cells Market includes

By Technology

• CTC Detection & Enrichment Methods
• Advanced CTC Detection Technologies

By Specimen

• Blood
• Bone Marrow
• Other Body Fluids

By Product

• Kits & Reagents
• Blood Collection Tubes
• Devices or Systems

By Application

• Clinical/Liquid Biopsy
• Research

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The UK
  • Germany
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East & Africa (MEA)
  • UAE
  • Saudi Arabia
  • Rest of MEA
• South America
  • Argentina
  • Brazil
  • Rest of South America

COMTEX_443441413/2796/2023-11-14T02:01:12

MENAFN14112023007451016085ID1107419987